Thursday, April 26, 2018

Two China biotechs drop U.S. IPO plans for $800 mln Hong Kong floats -sources

* Ascentage picks Hong Kong over U.S. due to new HKEX rules -chief
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)